People with chronic kidney or heart diseases should refrain from taking allopurinol — the most common drug used to treat high uric acid levels — with more than 20 people dying each year due to severe allergic reactions to the drug, the Linkou Chang Gung Memorial Hospital said yesterday.
“Allopurinol was approved by the US Food Drug Administration as a drug to treat gout, cancer or chemotherapy-induced hyperuricemia, but it is one of the most common medications that can trigger potentially fatal allergic reactions,” the hospital’s Drug Hypersensitivity Clinical and Research Center director Chung Wen-hung (鐘文宏) said.
Chung said about 0.4 percent of patients taking the drug experienced severe allergic responses, such as drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome and toxic epidermal necrolysis, which has a mortality rate of between 18 and 32 percent.
To better understand the health risks of allopurinol, the center, in cooperation with the National Health Insurance Administration (NHIA), conducted a study of people who took the medication from 2005 to 2011.
“The study found that each year, 4.68 of every 1,000 individuals who took the drug suffered from allergic reactions, of whom 2.02 were admitted into hospitals and 0.39 died because of its side effects,” Chung said.
Chung said the research also found that people aged 60 and above, have impaired kidney functions or cardiovascular diseases were at a higher risk for allopurinol-induced allergic reactions.
People with both kidney and heart illnesses faced an ever greater risk of experiencing the potentially deadly side effects and a higher death rate, the study suggested.
As the medication is mainly excreted via the kidney, Chung said people with chronic renal diseases who take the drug are more likely to suffer from kidney and heart failure, or even sepsis, if they experience allergic reactions.
“Over the past decade, more than 20 people died each year because of the medication,” Chung said, urging physicians to avoid prescribing the drug to hyperuricemia patients who also have chronic kidney or heart diseases.
In the past, allopurinol was the only choice of drug for reducing uric acid levels, Chung said.
However, with the NHIA’s coverage of a new antihyperuricemic drug last year, the number of people suffering from allopurinol’s harmful side effects is expected to drop, he said.
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
The Ministry of Foreign Affairs (MOFA) is suspending retaliation measures against South Korea that were set to take effect tomorrow, after Seoul said it is updating its e-arrival system, MOFA said today. The measures were to be a new round of retaliation after Taiwan on March 1 changed South Korea's designation on government-issued alien resident certificates held by South Korean nationals to "South Korea” from the "Republic of Korea," the country’s official name. The move came after months of protests to Seoul over its listing of Taiwan as "China (Taiwan)" in dropdown menus on its new online immigration entry system. MOFA last week
RSS